1 A Pharma GmbH
1 A Pharma GmbH, headquartered in Germany, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of high-quality generic medicines. Founded in 2003, the company has established a strong presence across Europe, focusing on key operational regions that include Germany and other EU markets. With a diverse portfolio of products, 1 A Pharma is renowned for its commitment to quality and affordability, offering a wide range of therapeutic areas such as pain management, cardiovascular health, and infectious diseases. The company’s unique approach combines rigorous quality control with innovative manufacturing processes, ensuring that their products meet the highest standards. Recognised for its market position, 1 A Pharma has achieved significant milestones, including numerous product launches and partnerships that enhance its competitive edge. As a trusted name in the pharmaceutical sector, 1 A Pharma continues to contribute to improved healthcare outcomes across its operational regions.
DitchCarbon Score
How does 1 A Pharma GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
1 A Pharma GmbH's score of 62 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
1 A Pharma GmbH's reported carbon emissions
1 A Pharma GmbH, headquartered in Germany, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the company may still be engaged in industry-standard practices aimed at reducing environmental impact. As the pharmaceutical sector increasingly focuses on sustainability, 1 A Pharma GmbH may be exploring initiatives to align with broader climate goals, although specific details are not provided.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
1 A Pharma GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
